PALI Palisade Bio, Inc. - Common Stock
NASDAQ · Biotechnology · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Aug 10, 2026
$1.44
· of 52w range
· above low
· to high
$1.3252w low
$2.8652w high
Market Cap (MRQ)
$250M
P/E (TTM)
2.2
EPS (TTM)
$0.65
Revenue (TTM)
$500.0K
your badges
52W Range
$1–$3
Analyst Rating
BUY
Price Target
$10
P/E
2.2
ROE
-51.4%
Net Profit Margin
-6388.2%
Your badge strip is empty — pin a metric anywhere on this page.
PALI Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$1.44
Market Cap (MRQ)
$250M
P/E (TTM)
2.2
EPS (TTM)
$0.65
Revenue (TTM)
$500.0K
ROE (TTM)
-51.4%
52W Range
$1–$3
PALI Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
Stock splits
| Ex-date | Split | Type |
|---|---|---|
| April 8, 2024 | 1-for-15 | Reverse |
| Nov. 16, 2022 | 1-for-50 | Reverse |
| April 28, 2021 | 1-for-6 | Reverse |
| July 18, 2019 | 1-for-20 | Reverse |
| Jan. 9, 2017 | 1-for-13 | Reverse |
10-Year Performance Revenue, net income, margins and EPS trends
Revenue$02016-12-31 → 2025-12-31
EPS$-0.302020-12-31 → 2025-12-31
Free Cash Flow·2016-12-31 → 2024-12-31
Net margin-6388.2%2016-12-31 → 2023-12-31
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | PALI | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E (TTM) | 2.25Y avg ≈-3.8 | ≈-3.8 | · | · | |
| P/S (TTM) | 500.0 | · | 12.0 | Overvalued | |
| P/B (MRQ) | 2.15Y avg ≈382.8 | ≈382.8 | 6.9 | Undervalued | |
| Price / Cash Flow | -21.25Y avg ≈-199.8 | ≈-199.8 | · | · | |
| Price / Tangible Book | 1.85Y avg ≈382.8 | ≈382.8 | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | PALI | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Operating Margin (TTM) | -7069.8% | · | -303.8% | Weak | |
| Net Profit Margin (TTM) | -6388.2% | · | -391.6% | Weak | |
| ROA (TTM) | -47.7%5Y avg ≈-133.0% | ≈-133.0% | -43.7% | Top tier | |
| ROE (TTM) | -51.4%5Y avg ≈-182.7% | ≈-182.7% | -48.6% | Top tier |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | PALI | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Current Ratio (MRQ) | 24.35Y avg ≈9.4 | ≈9.4 | 4.0 | Strong liquidity | |
| Quick Ratio | 28.85Y avg ≈9.0 | ≈9.0 | 3.9 | Strong liquidity |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
| Metric | 5Y trend | PALI | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Revenue CAGR 3Y | 164.4% | · | · | · |
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
| Metric | 5Y trend | PALI | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Asset Turnover | 0.05Y avg ≈0.0 | ≈0.0 | 0.2 | Weak | |
| Revenue / Employee | ≈$0.00 | · | · | · |
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
2.3%
Next Report
Nov 09, 2026
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2026 | Aug 10, 2026 | $-0.05 | $-0.05 | 6.2% |
| March 31, 2026 | May 11, 2026 | $-0.05 | $-0.04 | -14.4% |
| Dec. 31, 2025 | $-0.08 | $-0.08 | 3.5% | |
| Sept. 30, 2025 | $-0.38 | $-0.28 | -35.8% | |
| June 30, 2025 | $-0.58 | $-0.57 | -1.4% | |
| March 31, 2025 | $-0.47 | $-0.71 | 34.2% | |
| Dec. 31, 2024 | $-1.55 | $-2.03 | 23.7% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $250.0K | $0 | · | $13.5K | $15.4K | $260.0K | $260.0K | $16.2K | $10.4K | $18.8K | |
| R&D Expense | · | $16M | · | · | · | $2M | $4M | $4M | $8M | $13M | $13M | $8M | |
| SG&A Expense | $8M | $6M | $6M | $9M | $9M | $6M | $5M | $5M | $5M | $7M | $7M | $9M | |
| Operating Expenses | $18M | $15M | $13M | $16M | $42M | $9M | $9M | $9M | $14M | $21M | $19M | $17M | |
| Operating Income | $-18M | $-15M | $-13M | $-16M | $-42M | $-9M | $-9M | $-8M | $-13M | $-21M | $-19M | $-17M | |
| Interest Expense | · | $12.0K | $15.0K | $13.0K | $2M | $235.0K | $8.9K | $7.7K | $159.1K | $1M | $2M | $2M | |
| Interest Income | · | · | · | · | · | $33.5K | $67.7K | $78.8K | $70.3K | $58.8K | $69.5K | $67.7K | |
| Other Non-op | $1M | $433.0K | $785.0K | $3M | $47.0K | $13.0K | $280.0K | $3M | $-2M | $-437.8K | $-2M | $0 | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $1.0K | · | · | · | $0 | $0 | $0 | |
| Net Income | $-17M | $-14M | $-12M | $-14M | $-27M | $-10M | $-8M | $-5M | $-16M | $-21M | $-21M | $-23M | |
| EPS (Basic) | $-0.30 | $-10.19 | $-27.01 | $-16.53 | $-142.95 | $-3.72 | · | · | · | · | · | · | |
| EPS (Diluted) | $-0.30 | $-10.19 | $-27.01 | $-16.53 | $-169.74 | $-3.72 | · | · | · | · | · | · | |
| Shares (Basic) | 55,669,821 | 1,416,471 | 456,014 | 880,311 | 186,195 | 2,774,370 | · | · | · | · | · | · | |
| Shares (Diluted) | 55,669,821 | 1,416,471 | 456,014 | 880,311 | 186,958 | 2,774,370 | · | · | · | · | · | · | |
| EBITDA | $-18M | $-15M | $-13M | $-16M | $-42M | $-11M | $-9M | $-8M | $-13M | $-21M | $-19M | $-17M |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $133M | $10M | $12M | $12M | $10M | $713.0K | $5M | $6M | $7M | $15M | $5M | $13M | |
| Short-term Investments | · | · | · | · | · | · | · | · | $5M | $5M | $8M | $15M | |
| Receivables | $0 | $0 | · | $0 | $0 | $59.0K | $21.1K | $294.1K | $312.8K | $10.5K | $37.3K | $225.5K | |
| Prepaid Expense | $836.0K | $673.0K | $896.0K | $2M | $1M | $124.0K | $510.9K | $363.3K | $402.3K | $646.2K | $1M | $274.1K | |
| Current Assets | $134M | $10M | $13M | $15M | $12M | $896.0K | $6M | $7M | $12M | $21M | $13M | $28M | |
| PP&E (Net) | $0 | $3.0K | $10.0K | $10.0K | $3.0K | $5.0K | $41.0K | $90.3K | $172.9K | $269.6K | $343.2K | $301.3K | |
| PP&E (Gross) | · | · | · | · | · | $916.0K | $991.5K | $992.6K | $994.8K | $994.3K | $971.8K | $784.5K | |
| Accum. Depreciation | · | · | · | · | · | $905.2K | $950.4K | $902.3K | $821.9K | $724.8K | $628.6K | $483.2K | |
| Intangibles | · | · | · | · | · | $147.1K | $668.9K | $763.5K | $883.5K | $990.2K | $1M | $1M | |
| Other Non-current Assets | $68.0K | $273.0K | $490.0K | $694.0K | $868.0K | · | · | $24.0K | $13.9K | $15.7K | $71.8K | $58.7K | |
| Total Assets | $134M | $11M | $14M | $16M | $13M | $3M | $7M | $8M | $14M | $23M | $15M | $30M | |
| Accounts Payable | $767.0K | $1M | $698.0K | $2M | $1M | $3M | · | · | · | · | · | · | |
| Accrued Liabilities | $2M | $1M | $831.0K | $574.0K | $463.0K | $3M | · | · | · | · | · | · | |
| Current Liabilities | $5M | $3M | $3M | $3M | $2M | $8M | $1M | $1M | $2M | $7M | $6M | $4M | |
| Capital Leases | · | $0 | $90.0K | $211.0K | $0 | $112.0K | $148.5K | · | · | · | · | · | |
| Other Non-current Liabilities | · | $150.0K | · | · | · | · | · | · | · | · | · | · | |
| Total Liabilities | $5M | $3M | $3M | $3M | $5M | $10M | $1M | $2M | $5M | $11M | $10M | $12M | |
| Long-term Debt | · | · | · | · | $87.0K | $1M | · | · | · | · | $8M | $9M | |
| Total Debt | · | · | · | · | $87.0K | · | · | · | · | $4M | $8M | $9M | |
| Common Stock | $2M | $27.0K | $6.0K | $30.0K | $3.0K | $28.0K | $38.7K | $9.1K | $151.6K | $110.3K | $70.8K | $877.9K | |
| Paid-in Capital | $281M | $143M | $133M | $122M | $102M | $51M | $227M | $220M | $217M | $204M | $177M | $168M | |
| Retained Earnings | · | $136M | $122M | $109M | $95M | $-68M | $-222M | $-214M | $-209M | $-193M | $-172M | $-151M | |
| AOCI | · | · | · | · | · | $-734 | $-6.2K | $-413 | $2.6K | $3.9K | $3.1K | $6.0K | |
| Stockholders' Equity | $129M | $7M | $11M | $12M | $7M | $-17M | $-8M | $6M | $9M | $11M | $5M | $18M | |
| Liabilities + Equity | $134M | $11M | $14M | $16M | $13M | $3M | $7M | $8M | $14M | $23M | $15M | $30M | |
| Shares Outstanding | 159,444,017 | 2,768,646 | 618,056 | 2,944,306 | 284,780 | 2,774,502 | 3,866,457 | 910,253 | 15,160,014 | 11,032,858 | 7,077,362 | 87,789,679 |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | $3.0K | $2.0K | $3.0K | $143.9K | $185.8K | $289.2K | $337.5K | $345.5K | $348.6K | |
| Stock-based Comp | $4M | $652.0K | $624.0K | $1M | $2M | $2M | $880.8K | $634.1K | $2M | $3M | $3M | $4M | |
| Deferred Tax | · | · | · | · | $0 | $0 | $456.0K | $-3M | $19M | $-7M | $-8M | $-6M | |
| Amort. of Intangibles | · | · | · | · | · | $63.0K | $95.0K | $102.0K | $189.0K | $176.0K | $197.0K | $211.0K | |
| Operating Cash Flow | $-11M | $-12M | $-11M | $-13M | $-15M | $-5M | $-7M | $-8M | $-13M | $-16M | $-19M | $-12M | |
| CapEx | · | $0 | $4.0K | $10.0K | $0 | $6.0K | · | $1.7K | $11.4K | $98.1K | $176.3K | $207.9K | |
| Investing Cash Flow | · | $0 | $-4.0K | $-10.0K | $-54.0K | $-6.0K | · | $5M | $-94.0K | $2M | · | · | |
| Debt Issued | · | · | · | · | · | · | · | · | · | · | $0 | $4M | |
| Net Debt Issued | · | · | · | · | · | · | · | · | $-4M | $-5M | $-1M | $2M | |
| Stock Issued | $128M | $8M | $9M | $14M | $5M | $1M | · | · | · | · | $3M | · | |
| Net Stock Activity | $128M | $8M | $9M | $14M | $5M | · | · | · | · | · | · | · | |
| Financing Cash Flow | $134M | $10M | $11M | $15M | $25M | $2M | $7M | $2M | $5M | $24M | · | · | |
| Net Change in Cash | $124M | $-3M | $49.0K | $2M | $10M | $-3M | $-672.2K | $-887.8K | $-9M | $10M | $-8M | $-4M | |
| Free Cash Flow | · | $-12M | $-11M | $-13M | $-15M | · | · | $-8M | $-13M | $-16M | $-19M | $-12M |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | -5228.0% | · | · | -78961.1% | -56071.8% | -3176.7% | -5118.1% | -127027.2% | -183896.8% | -92581.4% | |
| Net Margin | · | · | -4920.0% | · | · | -120316.7% | -54252.6% | -1894.1% | -6025.4% | -129721.8% | -200671.0% | -120154.7% | |
| EBITDA Margin | · | · | -5228.0% | · | · | -78961.1% | -56071.8% | -3176.7% | -5118.1% | -127027.2% | -183896.8% | -92581.4% | |
| ROA | -23.1% | -115.8% | -82.5% | -100.9% | -342.8% | -165.7% | -117.1% | -45.7% | -85.9% | -112.2% | -93.1% | -91.9% | |
| ROE | -25.4% | -204.8% | -96.9% | -114.5% | -471.7% | 1056.6% | -137.3% | -93.5% | -157.9% | -258.6% | -184.3% | -173.2% |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 29.0 | 3.2 | 5.2 | 4.9 | 5.0 | 4.0 | 4.6 | 6.2 | 8.2 | 2.9 | 2.1 | 7.0 | |
| Quick Ratio | 28.8 | 3.0 | 4.8 | 4.1 | 4.2 | 3.3 | 4.2 | 5.8 | 7.9 | 2.8 | 1.9 | 6.9 | |
| Debt / Equity | · | · | · | · | 0.0 | · | · | · | · | 0.3 | 1.6 | 0.5 | |
| LT Debt / Equity | · | · | · | · | 0.0 | · | · | · | · | · | 0.7 | 0.5 | |
| Interest Coverage | · | -1238.2 | -871.3 | -1209.3 | -17.5 | -761.7 | -967.7 | -1072.9 | -83.7 | -18.1 | -10.5 | -10.8 |
Efficiency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | 0.0 | · | · | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Receivables Turnover | · | · | · | · | · | 0.2 | 0.1 | 0.9 | 1.6 | 0.7 | 0.1 | 0.2 |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.81 | $2.71 | $1.22 | $4.24 | $0.52 | $0.56 | $1.33 | $0.33 | $0.56 | $1.03 | $0.05 | $0.20 | |
| Revenue / Share | $0.00 | $0.00 | $0.04 | · | · | · | · | · | · | · | · | · | |
| Cash Flow / Share | $-0.19 | $-8.61 | $-1.63 | $-15.18 | $-1.58 | · | · | · | · | · | · | · | |
| Cash / Share | $0.84 | $3.55 | $1.34 | $4.21 | $0.74 | $0.61 | $1.32 | $0.32 | $0.44 | $1.38 | $0.05 | $0.14 | |
| EPS (TTM) | $-0.30 | $-10.19 | $-27.01 | $-16.53 | $-169.74 | $-3.72 | · | · | · | · | · | · |
Growth Rates
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue CAGR 3Y | · | · | 164.4% | · | · | · | · | · | · | · | · | · |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $0 | $250.0K | $0 | $13.5K | $13.5K | $15.4K | $260.0K | $260.0K | $16.2K | $10.4K | $18.8K | |
| Net Income TTM | $-17M | $-14M | $-12M | $-14M | $-27M | $-10M | $-8M | $-5M | $-16M | $-21M | $-21M | $-23M | |
| Market Cap | $375M | $5M | $82M | $230M | $13.88B | $68.49B | $17.23B | $507.92B | $2.35T | $3.49T | $110.88T | $279.38T | |
| Enterprise Value | · | · | · | · | $13.87B | · | · | · | · | $3.49T | $110.88T | $279.38T | |
| P/E | -7.8 | -0.2 | -0.3 | -4.7 | -5.7 | -1064.5 | · | · | · | · | · | · | |
| P/S | · | · | 328.2 | · | 1026863.7 | 5065901.2 | 1118946.7 | 1953543.0 | 9026039.1 | 214531567.3 | 10643762608.8 | 14834698372.5 | |
| P/B | 2.9 | 0.6 | 7.3 | 18.4 | 1885.0 | 7011.8 | 3360.3 | 83960.2 | 275600.1 | 307594.0 | 22321294.5 | 15767062.3 | |
| P / Tangible Book | 2.9 | 0.6 | 7.3 | 18.4 | 1885.0 | · | · | · | · | · | · | · | |
| P / Cash Flow | -34.5 | -0.4 | -7.4 | -17.2 | -939.8 | -7588.9 | -2374.0 | -66028.8 | -174921.1 | -223184.9 | -5856646.5 | -23865150.8 | |
| P / FCF | · | -0.4 | -7.4 | -17.2 | -939.8 | · | · | -66014.1 | -174772.6 | -221791.8 | -5802618.5 | -23448736.8 | |
| EV / EBITDA | · | · | · | · | -331.5 | · | · | · | · | -168885.5 | -5787900.1 | -16023415.6 | |
| EV / FCF | · | · | · | · | -939.1 | · | · | · | · | -221790.8 | -5802618.3 | -23448735.3 | |
| EV / Revenue | · | · | · | · | 1026093.9 | · | · | · | · | 214530552.3 | 10643762204.9 | 14834697377.5 | |
| Earnings Yield | -12.8% | -617.6% | -305.2% | -21.2% | -17.4% | -0.09% | · | · | · | · | · | · |
Income Statement
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $500.0K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $250.0K | $0 | $0 | |
| R&D Expense | $6M | $6M | · | · | · | · | $0 | $16M | · | · | $362.0K | · | · | · | · | · | |
| SG&A Expense | $5M | $4M | $4M | $2M | $1M | $1M | $1M | $1M | $2M | $1M | $2M | $2M | $1M | $2M | $2M | $2M | |
| Operating Expenses | $12M | $11M | $10M | $3M | $3M | $2M | $3M | $4M | $4M | $4M | $3M | $4M | $4M | $3M | $4M | $4M | |
| Operating Income | $-12M | $-11M | $-10M | $-3M | $-3M | $-2M | $-3M | $-4M | $-4M | $-4M | $-3M | $-4M | $-4M | $-3M | $-4M | $-4M | |
| Interest Expense | · | · | · | $5.0K | $2.0K | $1.0K | · | $6.0K | $2.0K | $1.0K | $4.0K | $8.0K | $3.0K | $0 | $3.0K | $4.0K | |
| Other Non-op | $1M | $1M | $1M | $59.0K | $61.0K | $81.0K | $41.0K | $112.0K | $133.0K | $147.0K | $187.0K | $190.0K | $219.0K | $189.0K | $131.0K | $426.0K | |
| Net Income | $-11M | $-10M | $-9M | $-3M | $-3M | $-2M | $-3M | $-3M | $-4M | $-4M | $-3M | $-4M | $-3M | $-2M | $-4M | $-4M | |
| EPS (Basic) | $-0.05 | $-0.05 | $1.13 | $-0.38 | $-0.58 | $-0.47 | $0.04 | $-2.32 | $-3.32 | $-4.59 | $-3.57 | $-7.38 | $-7.93 | $-8.13 | $6.30 | $-4.10 | |
| EPS (Diluted) | $-0.05 | $-0.05 | $1.13 | $-0.38 | $-0.58 | $-0.47 | $0.04 | $-2.32 | $-3.32 | $-4.59 | $-3.57 | $-7.38 | $-7.93 | $-8.13 | $6.30 | $-4.10 | |
| Shares (Basic) | 211,381,969 | 209,663,966 | · | 7,473,898 | 4,797,196 | 4,795,646 | · | 1,500,409 | 1,228,453 | 768,137 | · | 489,624 | 427,862 | 287,702 | · | 974,197 | |
| Shares (Diluted) | 211,381,969 | 209,663,966 | · | 7,473,898 | 4,797,196 | 4,795,646 | · | 1,500,409 | 1,228,453 | 768,137 | · | 489,624 | 427,862 | 287,702 | · | 974,197 | |
| EBITDA | $-12M | $-11M | · | $-3M | $-3M | $-2M | · | $-4M | $-4M | $-4M | · | $-4M | $-4M | $-3M | · | $-4M |
Balance Sheet
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $125M | $133M | $133M | $5M | $5M | $7M | $10M | $8M | $11M | $11M | $12M | $15M | $16M | $13M | $12M | $14M | |
| Receivables | $500.0K | · | · | · | · | · | · | · | · | · | · | · | · | $250.0K | · | · | |
| Prepaid Expense | $2M | $615.0K | $836.0K | $2M | $1M | $657.0K | $673.0K | $830.0K | $959.0K | $737.0K | $896.0K | $954.0K | $1M | $762.0K | $2M | $1M | |
| Current Assets | $127M | $133M | $134M | $7M | $6M | $8M | $10M | $9M | $12M | $12M | $13M | $16M | $17M | $14M | $15M | $15M | |
| PP&E (Net) | · | · | $0 | $0 | $1.0K | $2.0K | $3.0K | $3.0K | $4.0K | $5.0K | $10.0K | $10.0K | $11.0K | $9.0K | $10.0K | $12.0K | |
| Other Non-current Assets | $0 | $17.0K | $68.0K | $119.0K | $171.0K | $222.0K | $273.0K | $324.0K | $387.0K | $438.0K | $490.0K | $541.0K | $592.0K | $643.0K | $694.0K | $746.0K | |
| Total Assets | $127M | $133M | $134M | $7M | $7M | $8M | $11M | $9M | $13M | $13M | $14M | $17M | $18M | $15M | $16M | $16M | |
| Accounts Payable | $2M | $3M | $767.0K | $1M | $1M | $745.0K | $1M | $366.0K | $514.0K | $459.0K | $698.0K | $950.0K | $922.0K | $706.0K | $2M | $2M | |
| Accrued Liabilities | $3M | $3M | $2M | $1M | $2M | $2M | $1M | $2M | $2M | $2M | $831.0K | $794.0K | $598.0K | $309.0K | $574.0K | $1M | |
| Current Liabilities | $5M | $6M | $5M | $3M | $4M | $3M | $3M | $3M | $3M | $2M | $3M | $3M | $2M | $1M | $3M | $4M | |
| Capital Leases | · | · | · | · | · | · | · | $0 | $24.0K | $58.0K | $90.0K | $122.0K | $153.0K | $182.0K | $211.0K | $239.0K | |
| Other Non-current Liabilities | · | · | · | $283.0K | · | · | · | · | · | · | · | · | · | · | · | · | |
| Total Liabilities | $6M | $6M | $5M | $4M | $4M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $2M | $2M | $3M | $4M | |
| Common Stock | $2M | $2M | $2M | $91.0K | $48.0K | $43.0K | $27.0K | $11.0K | $9.0K | $8.0K | $6.0K | $92.0K | $69.0K | $46.0K | $30.0K | $771.0K | |
| Paid-in Capital | $293M | $288M | $281M | $147M | $144M | $143M | $143M | $139M | $139M | $135M | $133M | $133M | $131M | $125M | $122M | $117M | |
| Retained Earnings | · | · | · | · | $141M | $138M | · | $133M | $-129M | $-125M | · | $118M | $115M | $112M | · | $105M | |
| Stockholders' Equity | $122M | $127M | $129M | $3M | $3M | $5M | $7M | $7M | $10M | $10M | $11M | $14M | $16M | $14M | $12M | $12M | |
| Liabilities + Equity | $127M | $133M | $134M | $7M | $7M | $8M | $11M | $9M | $13M | $13M | $14M | $17M | $18M | $15M | $16M | $16M | |
| Shares Outstanding | 173,595,201 | 167,421,702 | 159,444,017 | 9,119,152 | 4,800,247 | 4,396,646 | 2,768,646 | 1,198,516 | 966,345 | 851,302 | 618,056 | 9,210,751 | 6,849,362 | 4,563,977 | 2,944,306 | 77,080,169 |
Cash Flow
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | · | · | · | · | · | · | $1.0K | $2.0K | $1.0K | · | $0 | |
| Stock-based Comp | $5M | $4M | $4M | $90.0K | $69.0K | $69.0K | $77.0K | $95.0K | $362.0K | $118.0K | $185.0K | $202.0K | $144.0K | $93.0K | $86.0K | $252.0K | |
| Operating Cash Flow | $-8M | $-4M | $-3M | $-4M | $-2M | $-2M | $-2M | $-3M | $-3M | $-3M | $-3M | $-3M | $-2M | $-4M | $-3M | $-3M | |
| CapEx | · | · | · | · | · | · | · | $0 | · | · | $0 | $0 | · | · | $10.0K | $0 | |
| Investing Cash Flow | · | · | · | · | · | · | · | $0 | · | · | $0 | $0 | · | · | $-10.0K | $0 | |
| Stock Issued | $0 | $3M | $128M | $0 | $0 | $0 | $4M | $0 | $4M | $0 | $0 | $2M | $5M | $2M | $0 | $13M | |
| Net Stock Activity | · | $3M | · | · | · | · | · | · | · | $0 | · | · | · | $2M | · | · | |
| Financing Cash Flow | $147.0K | $3M | $131M | $3M | $4.0K | $-258.0K | $4M | $-180.0K | $4M | $2M | $-134.0K | $2M | $5M | $4M | $2M | $12M | |
| Net Change in Cash | $-7M | $-757.0K | $128M | $-190.0K | $-2M | $-3M | $2M | $-3M | $77.0K | $-1M | $-3M | $-1M | $3M | $914.0K | $-2M | $9M |
Profitability
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -2339.6% | · | · | · | · | · | · | · | · | · | · | · | · | -1011.6% | · | · | |
| Net Margin | -2114.8% | · | · | · | · | · | · | · | · | · | · | · | · | -936.0% | · | · | |
| EBITDA Margin | -2339.6% | · | · | · | · | · | · | · | · | · | · | · | · | -1011.6% | · | · | |
| ROA | -15.8% | -13.6% | · | -35.2% | -28.5% | -21.4% | · | -26.4% | -26.2% | -25.3% | · | -21.6% | -26.0% | -19.8% | · | -24.5% | |
| ROE | -17.0% | -14.5% | · | -58.4% | -44.3% | -29.0% | · | -33.7% | -31.7% | -29.6% | · | -27.1% | -33.9% | -25.2% | · | -48.8% |
Liquidity & Solvency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 24.3 | 23.7 | · | 2.0 | 1.6 | 2.8 | · | 3.3 | 4.3 | 4.9 | · | 6.1 | 7.5 | 10.9 | · | 4.3 | |
| Quick Ratio | 24.0 | 23.6 | · | 1.5 | 1.4 | 2.6 | · | 3.0 | 4.0 | 4.6 | · | 5.8 | 7.0 | 10.3 | · | 4.0 | |
| Interest Coverage | · | · | · | -584.4 | -1421.5 | -2310.0 | · | -598.8 | -2105.5 | -3673.0 | · | -472.2 | -1203.0 | · | · | -1103.2 |
Efficiency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | · | |
| Receivables Turnover | 1.8 | · | · | · | · | · | · | · | · | · | · | · | · | 1.8 | · | · |
Per Share
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.70 | $0.76 | · | $0.35 | $0.55 | $1.21 | · | $5.51 | $10.30 | $11.82 | · | $1.53 | $2.31 | $3.01 | · | $0.16 | |
| Revenue / Share | $0.00 | $0.00 | · | $0.00 | $0.00 | $0.00 | · | $0.00 | $0.00 | $0.00 | · | $0.00 | $0.00 | $0.06 | · | · | |
| Cash Flow / Share | · | $-0.02 | · | · | · | $-0.49 | · | · | · | $-4.14 | · | · | · | $-0.82 | · | · | |
| Cash / Share | $0.72 | $0.79 | · | $0.57 | $1.13 | $1.64 | · | $6.71 | $11.75 | $13.25 | · | $1.66 | $2.39 | $2.91 | · | $0.18 | |
| EPS (TTM) | $0.65 | $0.12 | · | $-1.39 | $-3.33 | $-6.07 | · | $-13.80 | $-18.86 | $-23.47 | · | $-17.14 | $-13.86 | $-11.70 | · | $-188.44 |
Valuation (TTM)
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $500.0K | $0 | · | $0 | $0 | $0 | · | $0 | $0 | $0 | · | $250.0K | $250.0K | $250.0K | · | · | |
| Net Income TTM | $-32M | $-24M | · | $-11M | $-12M | $-13M | · | $-14M | $-14M | $-13M | · | $-13M | $-13M | $-12M | · | $-9M | |
| Market Cap | $363M | $293M | · | $8M | $3M | $3M | · | $4M | $4M | $5M | · | $80M | $175M | $241M | · | $5.78B | |
| P/E | 3.2 | 14.6 | · | -0.6 | -0.2 | -0.1 | · | -0.3 | -0.2 | -0.3 | · | -0.5 | -1.8 | -4.5 | · | -0.4 | |
| P/S | 725.6 | · | · | · | · | · | · | · | · | · | · | 320.5 | 698.6 | 963.9 | · | · | |
| P/B | 3.0 | 2.3 | · | 2.4 | 1.2 | 0.6 | · | 0.6 | 0.4 | 0.5 | · | 5.7 | 11.1 | 17.5 | · | 465.1 | |
| P / Tangible Book | 3.0 | 2.3 | · | 2.4 | 1.2 | 0.6 | · | 0.6 | 0.4 | 0.5 | · | 5.7 | 11.1 | 17.5 | · | 465.1 | |
| P / Cash Flow | · | -75.3 | · | · | · | -1.3 | · | · | · | -1.6 | · | · | · | -68.3 | · | · | |
| Earnings Yield | 31.1% | 6.9% | · | -161.6% | -489.7% | -892.7% | · | -388.7% | -419.1% | -391.2% | · | -197.0% | -54.4% | -22.2% | · | -251.3% |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $250.0K | $0 | · |
| Operating Margin % | · | · | -5228.0% | · | · |
| Net Income | $-17M | $-14M | $-12M | $-14M | $-27M |
| Diluted EPS | $-0.30 | $-10.19 | $-27.01 | $-16.53 | $-169.74 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Debt / Equity | · | · | · | · | 0.0 |
| Current Ratio | 29.0 | 3.2 | 5.2 | 4.9 | 5.0 |
| Quick Ratio | 28.8 | 3.0 | 4.8 | 4.1 | 4.2 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Free Cash Flow | · | $-12M | $-11M | $-13M | $-15M |
Institutional owners (13F) 125 filers · $363.1M total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
125
Value held
$363.1M
New positions
50
Exited positions
21
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 50 (+19 vs prior Q) | 21 (+1 vs prior Q) | 33 (+4 vs prior Q) | 23 (-2 vs prior Q) | +24.7M |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| Soleus Capital Management, L.P. | $27,303,106 | 13,063,687 | 7.52% | Shares |
| B Group, Inc. | $23,855,856 | 11,414,285 | 6.57% | Shares |
| AMERIPRISE FINANCIAL INC | $23,160,197 | 11,081,434 | 6.38% | Shares |
| BlackRock, Inc. | $21,812,829 | 10,436,760 | 6.01% | Shares |
| Octagon Capital Advisors LP | $21,477,503 | 10,276,317 | 5.92% | Shares |
| JANUS HENDERSON GROUP PLC | $18,759,988 | 10,689,452 | 5.17% | Shares |
| PERCEPTIVE ADVISORS LLC | $17,608,386 | 8,425,065 | 4.85% | Shares |
| RA CAPITAL MANAGEMENT, L.P. | $14,889,402 | 7,124,116 | 4.10% | Shares |
| FRANKLIN RESOURCES INC | $12,091,045 | 5,785,189 | 3.33% | Shares |
| Point72 Asset Management, L.P. | $10,979,612 | 5,253,403 | 3.02% | Shares |
| Boxer Capital Management, LLC | $10,031,739 | 4,799,875 | 2.76% | Shares |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $9,405,000 | 4,500,000 | 2.59% | Shares |
| Eversept Partners, LP | $8,742,021 | 4,182,785 | 2.41% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $7,861,359 | 3,760,485 | 2.17% | Shares |
| WELLINGTON MANAGEMENT GROUP LLP | $7,741,226 | 3,703,936 | 2.13% | Shares |
| GOLDMAN SACHS GROUP INC | $7,478,062 | 3,578,020 | 2.06% | Shares |
| FEDERATED HERMES, INC. | $6,555,509 | 3,136,607 | 1.81% | Shares |
| Squadron Capital Management LLC | $6,270,000 | 3,000,000 | 1.73% | Shares |
| Propel Bio Management, LLC | $5,397,191 | 2,582,388 | 1.49% | Shares |
| Vestal Point Capital, LP | $5,225,000 | 2,500,000 | 1.44% | Shares |
| STATE STREET CORP | $5,174,104 | 2,475,648 | 1.43% | Shares |
| MORGAN STANLEY | $5,170,803 | 2,474,069 | 1.42% | Shares |
| VANGUARD GROUP INC | $4,971,711 | 2,115,622 | 1.37% | Shares |
| ORBIMED ADVISORS LLC | $4,875,970 | 2,333,000 | 1.34% | Shares |
| GREAT POINT PARTNERS LLC | $4,775,272 | 2,284,819 | 1.32% | Shares |
| SPHERA FUNDS MANAGEMENT LTD. | $4,717,352 | 2,257,106 | 1.30% | Shares |
| HighVista Strategies LLC | $4,244,638 | 2,030,927 | 1.17% | Shares |
| Siren, L.L.C. | $4,180,000 | 2,000,000 | 1.15% | Shares |
| Artia Global Partners LP | $4,164,047 | 1,992,367 | 1.15% | Shares |
| Aberdeen Group plc | $3,992,328 | 1,910,205 | 1.10% | Shares |
| Balyasny Asset Management L.P. | $3,920,200 | 1,875,694 | 1.08% | Shares |
| PLATINUM INVESTMENT MANAGEMENT LTD | $3,617,510 | 1,730,866 | 1.00% | Shares |
| ADAR1 Capital Management, LLC | $3,608,724 | 1,726,662 | 0.99% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $3,600,688 | 1,722,817 | 0.99% | Shares |
| Ally Bridge Group (NY) LLC | $2,568,610 | 1,229,000 | 0.71% | Shares |
| NORTHERN TRUST CORP | $2,503,026 | 1,197,620 | 0.69% | Shares |
| RENAISSANCE TECHNOLOGIES LLC | $2,350,832 | 1,124,800 | 0.65% | Shares |
| CITADEL ADVISORS LLC | $2,125,216 | 1,016,850 | 0.59% | Shares |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $2,077,659 | 994,095 | 0.57% | Shares |
| Nuveen, LLC | $2,026,165 | 969,457 | 0.56% | Shares |
| MILLENNIUM MANAGEMENT LLC | $1,952,384 | 934,155 | 0.54% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $1,851,556 | 885,912 | 0.51% | Shares |
| Ikarian Capital, LLC | $1,567,500 | 750,000 | 0.43% | Shares |
| UBS Group AG | $1,540,972 | 737,307 | 0.42% | Shares |
| BIT Capital GmbH | $1,199,660 | 574,000 | 0.33% | Shares |
| Simplify Asset Management Inc. | $941,635 | 450,543 | 0.26% | Shares |
| Creek Drive Management Group LLC | $919,600 | 440,000 | 0.25% | Shares |
| BOOTHBAY FUND MANAGEMENT, LLC | $913,616 | 437,137 | 0.25% | Shares |
| LANDSCAPE CAPITAL MANAGEMENT, L.L.C. | $912,758 | 436,726 | 0.25% | Shares |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $909,114 | 434,983 | 0.25% | Shares |
Activists & 5%+ owners 5 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| Yuma Regional Medical Center | Aug. 30, 2021 | · | Initial filing | M&A / sale | SEC |
| Tianjin Pharmaceuticals Group Holdings Co., Ltd, Tianjin Pharmaceuticals Group International Holdings Co., Ltd | Feb. 27, 2017 | · | Initial filing | Passive investment | SEC |
| Karl Johe ×2 filings | Feb. 4, 2015 | · | Initial filing | · | SEC |
| I.Richard Garr | Feb. 4, 2015 | · | Initial filing | · | SEC |
| I. Richard Garr | March 6, 2014 | · | Initial filing | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Company insiders 28 insiders · 10 officers · 22 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| John David Finley | CEO, CFO | Aug. 19, 2026 G | 88,451 | 0 | 2 | $-310,690 |
| Thomas Hallam | Chief Executive Officer | Aug. 16, 2022 P | 57,592 | 0 | 0 | $0 |
| Richard J Daly | Chief Executive Officer | Nov. 7, 2017 A | 23,312 | 0 | 0 | $0 |
| Richard Garr | CEO | Jan. 27, 2016 M | 1,449,804 | 0 | 0 | $0 |
| Jones Jonathan Brian Lloyd | Chief Financial Officer | March 24, 2017 P | 7,859 | 0 | 0 | $0 |
| John Conron | Chief Financial Officer | Jan. 28, 2011 A | 115,492 | 0 | 0 | $0 |
| Robert Curtis Mcrae | Chief Operating Officer | April 3, 2023 M | 625 | 0 | 0 | $0 |
| Mitchell Lawrence Jones | Chief Medical Officer | July 6, 2026 M | 94,009 | 0 | 2 | $-109,835 |
| Michael John Dawson | Chief Medical Officer | March 29, 2022 P | 15,000 | 0 | 0 | $0 |
| Karl Johe | Chief Scientific Officer | Nov. 19, 2015 M | 930,373 | 0 | 0 | $0 |
| Robert Baltera Jr. | Director | July 9, 2026 P | 461,904 | 6 | 0 | $250,100 |
| Jordan Michael Zwick | Director | June 10, 2026 A | 336,904 | 0 | 0 | $0 |
| Emil Chuang | Director | June 10, 2026 M | 612,500 | 0 | 0 | $0 |
| Binxian Wei | Director | June 10, 2026 M | 613,355 | 0 | 0 | $0 |
| Donald Allen Williams | Director | June 10, 2026 M | 1,570,294 | 2 | 0 | $17,750 |
| Margery B. Fischbein | Director | July 11, 2024 A | · | 0 | 0 | $0 |
| James R Neal | Director | Feb. 9, 2024 M | 10,920 | 0 | 0 | $0 |
| Stephanie Diaz | Director | Feb. 8, 2024 M | 12,800 | 0 | 0 | $0 |
| Robert J. Trenschel | Director | Feb. 8, 2024 M | 10,920 | 0 | 0 | $0 |
| Cristina Csimma | Director | Feb. 8, 2024 M | 12,862 | 0 | 0 | $0 |
| Mary Ann Gray | Director | Nov. 21, 2023 A | · | 0 | 0 | $0 |
| David J Mazzo | Director | April 1, 2021 A | · | 0 | 0 | $0 |
| William Clyde Oldaker | Director | July 1, 2019 A | 33,763 | 0 | 0 | $0 |
| Scott Varde Ogilvie | Director | July 1, 2019 A | 86,020 | 0 | 0 | $0 |
| Sandford D Smith | Director | July 1, 2019 A | 219,916 | 0 | 0 | $0 |
| Stanley Westreich | Director | July 2, 2018 A | 143,281 | 0 | 0 | $0 |
| Catherine A. Sohn | Director | July 1, 2015 A | 106,952 | 0 | 0 | $0 |
| REGAL ONE CORP | 10% owner | March 13, 2007 J | 1,293,814 | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 11 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| IWC · iShares Trust | 0.07% | 499,629 SH | Sept. 11, 2026 | Daily |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0.02% | 105,506 SH | Aug. 19, 2026 | Daily |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.01% | 847,978 SH | Aug. 19, 2026 | Daily |
| IWM · iShares Trust | 0.01% | 3,786,930 SH | Sept. 11, 2026 | Daily |
| RSSL · Global X Funds | 0.01% | 70,212 NS | July 31, 2026 | N-PORT |
| IWO · iShares Trust | 0.00% | 246,405 SH | Sept. 11, 2026 | Daily |
| ITOT · iShares Trust | 0.00% | 383,511 SH | Sept. 11, 2026 | Daily |
| VXF · VANGUARD INDEX FUNDS | 0.00% | 1,722,817 SH | Aug. 19, 2026 | Daily |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0.00% | 28,274 SH | Aug. 19, 2026 | Daily |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 12,337 SH | Aug. 19, 2026 | Daily |
| IWN · iShares Trust | · | 1,110,816 SH | Sept. 11, 2026 | Daily |
PALI Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 16 analysts
BUY
Median target
$8.00
+455.6%
6 37.5%
Strong Buy
9 56.2%
Buy
1 6.2%
Hold
0 0.0%
Sell
0 0.0%
Strong Sell
12-Month Price Target
9 analysts · 2026-09-28Mean target $10.22 +609.9%
← Below all targets
Current price $1.44
Low$5.00
Mean$10.22
High$25.00
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| PALI | $375M | -7.8 | · | · | -25.4% | · |
| IMRX | · | -5.2 | · | · | -45.3% | · |
| ANIK | $133M | -12.6 | -5.9% | -9.6% | -7.5% | 56.6% |
| STRO | $99M | -0.5 | 65.2% | -186.5% | 232.2% | · |
| CAMP | $318M | -2.3 | 436.5% | -2298.5% | -183.4% | · |
| EVMN | $540M | -1.5 | 85.7% | -529.8% | -401.2% | · |
| GLSI | $300M | -14.7 | · | · | -2159.7% | · |
| QTTB | $43M | 1.4 | · | 55.5% | 200.3% | · |
| IVVD | $697M | -8.2 | 110.5% | -98.2% | -36.9% | · |
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 10-Q filed Aug 10, 2026